hero section gradient
15 handpicked stocks

AI's Billion-Dollar Breakthrough

Palantir's record-breaking $1 billion revenue quarter showcases the immense growth in the artificial intelligence sector. This trend creates a significant opportunity for companies that provide the foundational technology, including AI software, semiconductor hardware, and cloud infrastructure.

Author avatar

Han Tan | Market Analyst

Published on August 5

Your Basket's Financial Footprint

Interpretation of the basket's market capitalisation and investor implications.

Key Takeaways for Investors:
  • Large-cap dominance generally means lower volatility and returns that tend to track broad market performance.
  • Suitable as a core holding for diversified portfolios, not as a speculative short-term trade.
  • Expect steady, long-term appreciation rather than explosive short-term gains; growth is likely moderate.
Total Market Cap
  • NVDA: $4.40T

  • MSFT: $3.85T

  • GOOGL: $3.03T

  • Other

About This Group of Stocks

1

Our Expert Thinking

Palantir's record-breaking £1 billion revenue quarter demonstrates the massive commercial potential of artificial intelligence. This milestone signals that AI has moved beyond experimental phases into widespread business adoption, creating opportunities across the entire technology ecosystem that powers these sophisticated systems.

2

What You Need to Know

This group focuses on the foundational technology providers that enable AI growth - from semiconductor manufacturers and cloud infrastructure giants to software innovators. These companies form the backbone of the AI revolution, providing the essential hardware, platforms, and services that make advanced AI applications possible.

3

Why These Stocks

These stocks were handpicked by professional analysts based on their strategic positioning within the AI value chain. Each company plays a crucial role in supporting the expanding AI ecosystem, from chip designers and cloud computing leaders to software platforms that enable AI deployment across industries.

Why You'll Want to Watch These Stocks

🚀

Riding the AI Revenue Wave

Palantir's billion-dollar milestone proves AI is generating serious commercial returns. Companies in this space are experiencing unprecedented demand as businesses rush to integrate AI capabilities.

Infrastructure Gold Rush

As AI adoption accelerates, the demand for powerful semiconductors, cloud computing, and specialised hardware is surging. These foundational companies are positioned at the centre of this technological transformation.

💎

Expert-Curated AI Leaders

This collection features the companies that analysts believe are best positioned to capitalise on the AI boom. From chip giants to cloud innovators, these are the names driving the industry forward.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions